Zaragoza, 27-28 April 2017

Are we able to detect new technologies

systematically and timely? Spanish emerging technologies network. Methodological advances and work plan.

E. Baños, S. Luengo, A. Llanos, C. Juárez, L Varela, JM. Ruiz-Olano I. Prieto, T. Molina, I. Gutiérrez-Ibarluzea, G. Benguria-Arrate, J. Asua

AETS, AETSA, AVALIA-T, OSTEBA

PUBLIC HEALTH CONFERENCE 10th anniversary of the Spanish Network of Health Technology Assessment (HTA) Agencies:

Insights for collaborative networking

Towards Patient and public engagement in HTA

Agenda

• Where we come from? • What is our way? • Changes over time • What can we offer? • What do we need from the system and from

our customers? • Future developments

New or emerging health technologies

• Emerging health technology A health technology that has not yet been adopted within the healthcare system. Pharmaceuticals are in the Phase II or III clinical trial, or pre-launch stage; medical devices are in the pre-marketing stage. • New health technology A health technology that is in the launch, early post-marketing, or early diffusion stages.

Source: https://www.euroscan.org/

Introduction of new and emerging health technologies

Innovation Development

Security and efficacy

Technology analysis

Technology Assessment Decision Clinical

Practice

Producers Buyers

Supliers Health professionals Professional bodies

Public Health

Politicians Mass-media Pressure groups (ej. Religion)

Patient organizations

Society

Patients

John Gabbay and Tom Walley Introducing new health interventions

BMJ, Jan 2006; 332: 64 - 6

Political strategists

When to evaluate?….When to inform?….

Experimental Clinical research

Acceptance Phase

Accepted and disseminated

Introduced into the system

Innovation

Amount of information

Assessment

Variability

Early dialogue

Inform

Diffusion control strategies

• Early awareness and alert system A system that aims to identify, filter and prioritisize new and emerging health technologies, or new uses of existing interventions; to assess or predict their impact on health, health services and/or society; and to disseminate information. • Horizon scanning The systematic identification of health technologies that are new, emerging or becoming obsolete and that have the potential to effect health, health services and/or society. • Regulation for the introduction Informative Normative • Rational use of the technology

IMPACTO DE LOS SISTEMAS DE IDENTIFICACIÓN-EVALUACIÓN DE TECNOLOGÍAS SANITARIAS NUEVAS Y EMERGENTES EN LA DIFUSIÓN-INTRODUCCIÓN DE DICHAS

TECNOLOGÍAS

Noviembre 2006

• I Gutiérrez-Ibarluzea1, S. Luengo2, R. Villegas3. L. Varela4,

• T. Cerdá4, J Asua1, N Egües-Olazabal1.

• 1 Osteba. Osasun Teknologien Ebaluazioa. Osasun Saila. Eusko Jaurlaritza. • 2 AETS-Carlos III, Madrid 3 AETSA-Sevilla, Andalucía 4Avalia-T Santiago de Compostela. Galicia.

Where we come from?......Opportunity

• Common working time – Experienced systems – Incipient systems – Not regulated established

collaboration

• Coordinated project between some health technology assessment agencies of regional Ministries of Health

“We are what we do, day by day. So excellence is not an act, its a habit”.

Aristotle

Objectives of the survey 2006

• To know the situation of the identification and evaluation of new and emerging technologies systems in the NHS

• To evaluate the current impact of its recommendations on the

dissemination of some health technologies • To establish the basis for a network of information on new

and emerging health technologies in the NHS

Methodology (survey 2006)

• Direct contact with the Spanish HTA organizations that have EWS / questionnaire description of those systems

• Analysis of its influence on the diffusion

Identification-assessment systems in the

National Health System – 2006-

SorTek

Detecta-T

Síntesis

Detecta

Conclusions (survey 2006)

• Different systems, methodology and similar action • 3 EuroScan members (AETS, AETSA and Osteba) • High degree of agreement on the recommendations issued • Early Assessment Systems (EAS) modify the diffusion ratios of

the technologies studied in health coverage contexts • Difficulties in obtaining data • Impact?

– Higher or lower by the degree of influence of close contexts without EAS.

New challenges…in 2006

• To improve identification methodology • To be more proactive with experts • To increase information sources • Benchmarking • To increase the number of experts involved • To expand the survey to other centers with information-

regulation systems in the NHS • To extend the experience to other communities with HTA

units • To create an stable network that adequately and timely

reports to the NHS

What is our way…? • To update the GENTecS Group's Early

Detection Strategy for New and Emerging Health Technologies in order to adapt it to current needs

• Autonomous entities and the General Directorate of Basic Service Portfolio of the MoH and Cohesion Fund of the Ministry of Health, Social Policies and Equality, and the Autonomous Communities, through the Performance, Insurance and Financing Commission, under the Interterritorial Council of the Spanish NHS.

A joint and harmonious work

Current actions • Development of a functional and

operational working model in collaboration with the Gerneral directorate of Basic Services Portfolio of the NHS and Cohesion Fund of the Ministry of Health, Social Policies and Equality.

• Translation and adaptation of the methodological tool created by EuroScan

• Adaptation of the PriTec prioritization tool for use in the prioritization of new and emerging health technologies.

Things that have changed • Interlocution with the NHS • Influence on the portfolio of

services • Presence in different

commissions • Persistence • Improvement and

methodological developments – Search – Prioritization – Evaluation – Format – GRADE

What can we offer? • A common database of new and

emerging health technologies. • Facilitate the more efficient and

exhaustive identification of technologies for the subsequent prioritization by the corresponding autonomous systems and by the Service Portfolio Directorate of the MoH.

• Staff strategy • Continuous evaluation and

improvement of the identification-assessment system.

What have we done already? • We continue working in a

coordinated and joint manner • We have generated a list of

new and emerging technologies in 2016 with 63 entries

• Attractive formats for

visualization and prioritization of the information about emerging technologies

What do we need from our system and from

our customers? • Who? • For what? • What? Needs • Which one first?

Priorities • When? Time • What? Information • How? Method

Future developments • Stakeholder engagement • Test different methodologies

in development – Identification – Prioritization – Elaboration of

recommendations • Evaluate the efficiency of the

system and its impact • Find new partners and

customers

What else..?

Gaizka Benguria Arrate Osteba, Basque Office for Health Technology Assessment Basque Health Department Alda Rekalde 39A - Bilbao g-benguria@euskadi.eus http://www.osakidetza.euskadi.eus/osteba https://www.facebook.com/pages/Osteba/365563420144977